HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Protect IP To Encourage Switching In Australia, Urges ASMI

Executive Summary

The Australian Self Medication Industry (ASMI) is calling for IP protection for successful prescription-to-OTC reclassification applications to encourage switching in Australia. 

Related Content

Pharmaceutical Society Of Australia Wants Pharmacy To ‘Draw A Line In The Sand’ And Stop Supplying Homeopathy
Supplements Industry Under Threat In Australia With 'Made In' Claim Restrictions
Health Marketing Round-Up: January 2019
Atomo Diagnostics Wins Approval For Australia’s First HIV Self-Test, And Secures WHO Endorsement
ASMI wants switch plan





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts